Ditchcarbon
  • Customers
  1. Organizations
  2. Novartis Pharmaceuticals Corporation
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 6 months ago

Novartis Pharmaceuticals Corporation

Company website

Novartis Pharmaceuticals Corporation, commonly referred to as Novartis, is a leading global healthcare company headquartered in the United States. Founded in 1996 through the merger of Ciba-Geigy and Sandoz, Novartis has established a strong presence in key operational regions, including Europe, Asia, and Latin America. Specialising in innovative pharmaceuticals, Novartis focuses on areas such as oncology, cardiology, immunology, and neuroscience. The company is renowned for its unique portfolio of patented medications and cutting-edge therapies, which have significantly advanced patient care. With a commitment to research and development, Novartis has achieved notable milestones, including the introduction of groundbreaking treatments that address unmet medical needs. As a prominent player in the pharmaceutical industry, Novartis continues to enhance its market position through strategic partnerships and a robust pipeline of new products.

DitchCarbon Score

How does Novartis Pharmaceuticals Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

100

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

27

Industry Benchmark

Novartis Pharmaceuticals Corporation's score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

100%

Let us know if this data was useful to you

Novartis Pharmaceuticals Corporation's reported carbon emissions

Inherited from Novartis AG

As of the latest available data, Novartis Pharmaceuticals Corporation does not report specific carbon emissions figures. The company is a current subsidiary of Novartis AG, which cascades its climate commitments and emissions data. Novartis AG has set ambitious targets to reduce its carbon footprint, aligning with industry standards and initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). While specific reduction targets for Novartis Pharmaceuticals Corporation are not detailed, the overarching commitments from Novartis AG indicate a strong focus on sustainability and climate action. The company is actively involved in initiatives like RE100, aiming for 100% renewable electricity, and the Race to Zero campaign, which underscores its dedication to achieving net-zero emissions. In summary, while Novartis Pharmaceuticals Corporation does not provide specific emissions data, it benefits from the climate strategies and targets set by its parent company, Novartis AG, reflecting a commitment to reducing carbon emissions and enhancing sustainability within the pharmaceutical industry.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201020112012201320142015201620172018201920202021202220232024
Scope 1
583,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
922,000,000
0,000,000,000
0,000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
00,000,000
Scope 3
-
-
000,000,000
000,000,000
000,000,000
000,000,000
-
000,000,000
000,000,000
000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Novartis Pharmaceuticals Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Novartis Pharmaceuticals Corporation is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Novartis Pharmaceuticals Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Jazz Pharmaceuticals

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 13 hours ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Cephalon, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 17 hours ago

Bausch Health Cos

CA
•
Pharmaceutical Preparation Manufacturing
Updated about 4 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250915.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy